<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study aimed to evaluate the effect of hyperbaric oxygen preconditioning (HBO2P) on ischemic metabolites and the <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> level after permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="1" pm="."><plain>HBO2P was administered: five treatments, one treatment per day </plain></SENT>
<SENT sid="2" pm="."><plain>The permanent rabbit MCAO models were induced by a modified transorbital approach </plain></SENT>
<SENT sid="3" pm="."><plain>The microdialysis procedures were performanced in the right peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> area and contralateral area </plain></SENT>
<SENT sid="4" pm="."><plain>MCAO decreased <z:chebi fb="105" ids="17234">glucose</z:chebi> levels while increasing <z:chebi fb="4" ids="24996">lactate</z:chebi>, <z:chebi fb="1" ids="15361">pyruvate</z:chebi> and <z:chebi fb="4" ids="24996">lactate</z:chebi>/<z:chebi fb="1" ids="15361">pyruvate</z:chebi> ratios </plain></SENT>
<SENT sid="5" pm="."><plain>Early increase of <z:chebi fb="3" ids="17754">glycerol</z:chebi> and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> were also shown </plain></SENT>
<SENT sid="6" pm="."><plain>HBO2P stabilized the <z:chebi fb="105" ids="17234">glucose</z:chebi> level and decreased the <z:chebi fb="4" ids="24996">lactate</z:chebi>/<z:chebi fb="1" ids="15361">pyruvate</z:chebi> ratios and <z:chebi fb="3" ids="17754">glycerol</z:chebi> in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> area </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, it inhibited the increase of the <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> level </plain></SENT>
<SENT sid="8" pm="."><plain>Our study demonstrated that MCAO led to the imbalance of brain energy metabolites and excitatory amino acids </plain></SENT>
<SENT sid="9" pm="."><plain>The modulation of energy metabolism and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> may be one of the factors contributing to the neuroprotective property of HBO2P </plain></SENT>
</text></document>